SZSE:002773 (China)
Â
Class A
Â¥
20.08
(-0.69%)
Nov 28
Business Description
Chengdu Kanghong Pharmaceutical Group Co Ltd
ISIN : CNE1000020C4
Share Class Description:
SZSE:002773: Class ACompare
Compare
Traded in other countries / regions
002773.China IPO Date
2015-06-26Description
Chengdu Kanghong Pharmaceutical Group Co Ltd is a pharmaceutical company. The company is engaged in the research and development, production, and sales of medicine, chemical medicine, and biological products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 882.55 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 872.11 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 16.24 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.5 | |||||
| 3-Year Book Growth Rate | 10.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 14.71 | |||||
| Future 3-5Y Total Revenue Growth Rate | 11.54 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.26 | |||||
| 9-Day RSI | 59.9 | |||||
| 14-Day RSI | 56.59 | |||||
| 6-1 Month Momentum % | -13.55 | |||||
| 12-1 Month Momentum % | 6.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.43 | |||||
| Quick Ratio | 7.88 | |||||
| Cash Ratio | 7.54 | |||||
| Days Inventory | 319.91 | |||||
| Days Sales Outstanding | 15.13 | |||||
| Days Payable | 225.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.88 | |||||
| Dividend Payout Ratio | 0.29 | |||||
| 3-Year Dividend Growth Rate | -18.8 | |||||
| Forward Dividend Yield % | 1.88 | |||||
| 5-Year Yield-on-Cost % | 0.93 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 1.95 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.54 | |||||
| Operating Margin % | 30.14 | |||||
| Net Margin % | 27.3 | |||||
| FCF Margin % | 30.07 | |||||
| ROE % | 14.86 | |||||
| ROA % | 13.61 | |||||
| ROIC % | 34.66 | |||||
| ROC (Joel Greenblatt) % | 55.3 | |||||
| ROCE % | 16.27 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.45 | |||||
| Forward PE Ratio | 12.95 | |||||
| PE Ratio without NRI | 15.39 | |||||
| Shiller PE Ratio | 27.89 | |||||
| Price-to-Owner-Earnings | 22.08 | |||||
| PS Ratio | 4.25 | |||||
| PB Ratio | 2.19 | |||||
| Price-to-Tangible-Book | 2.3 | |||||
| Price-to-Free-Cash-Flow | 14.01 | |||||
| Price-to-Operating-Cash-Flow | 12.54 | |||||
| EV-to-EBIT | 9.92 | |||||
| EV-to-EBITDA | 9.92 | |||||
| EV-to-Revenue | 2.99 | |||||
| EV-to-FCF | 9.41 | |||||
| Price-to-Projected-FCF | 1.82 | |||||
| Price-to-Graham-Number | 1.25 | |||||
| Price-to-Net-Current-Asset-Value | 3.4 | |||||
| Price-to-Net-Cash | 3.88 | |||||
| Earnings Yield (Greenblatt) % | 10.08 | |||||
| FCF Yield % | 7.12 | |||||
| Forward Rate of Return (Yacktman) % | 12.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chengdu Kanghong Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,369.941 | ||
| EPS (TTM) (Â¥) | 1.3 | ||
| Beta | 0.9 | ||
| Volatility % | 42.82 | ||
| 14-Day RSI | 56.59 | ||
| 14-Day ATR (Â¥) | 0.717704 | ||
| 20-Day SMA (Â¥) | 19.5595 | ||
| 12-1 Month Momentum % | 6.63 | ||
| 52-Week Range (Â¥) | 13.15 - 24.5 | ||
| Shares Outstanding (Mil) | 919.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chengdu Kanghong Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chengdu Kanghong Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chengdu Kanghong Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773)'s stock price today?
The current price of SZSE:002773 is ¥20.08. The 52 week high of SZSE:002773 is ¥24.50 and 52 week low is ¥13.15.
When is next earnings date of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773)?
The next earnings date of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) is .
Does Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) pay dividends? If so, how much?
The Dividend Yield %  of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) is 1.88% (As of Today), Highest Dividend Payout Ratio of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) was 0.3. The lowest was 0.11. And the median was 0.19. The  Forward Dividend Yield % of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) is 1.88%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers